Bowen Matthew — insider trades
Stock trades Bowen Matthew reported on SEC Form 4 at GLUE Monte Rosa Therapeutics, Inc..
- Oct 5, 2026: sold 13 shares of GLUE Monte Rosa Therapeutics, Inc. ($137)
Stock trades Bowen Matthew reported on SEC Form 4 at GLUE Monte Rosa Therapeutics, Inc..